Bionano to Participate in the H.C. Wainwright @ Home Event

Bionano Genomics (Nasdaq: BNGO) said CEO Erik Holmlin, PhD will participate in the H.C.

Rhea-AI Summary

Bionano Genomics (Nasdaq: BNGO) said CEO Erik Holmlin, PhD will participate in the H.C. Wainwright @ Home Event on October 15, 2025. The session runs 10:00 a.m. to 11:00 a.m. ET and will be available via webcast with a registration link.

A replay/recording will be posted on the company investor website at ir.bionano.com and remain available for at least 90 days after the event.

Argus Oct 7 session

-1.47% close to close Open Argus

Details

News Market Reaction – BNGO

On Oct 7, the day this news came out, BNGO closed 1.47% below the previous close.

Data tracked by StockTitan Argus for the Oct 7 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the H.C. Wainwright @ Home Event on Wednesday, October 15^th, 2025.

Conference & Webcast Details

Date:	October 15, 2025
Time:	10:00 a.m. to 11:00 a.m. ET
Presenter:	Erik Holmlin, PhD, CEO of Bionano
Webcast:	Link to Register

A replay / recording of the session will be available following the conference through the Bionano website at ir.bionano.com for at least 90 days.

About Bionano

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.

For more information, visit www.bionano.com or www.bionanolaboratories.com.

Bionano’s products are for research use only and not for use in diagnostic procedures.

Contacts

Company Contact:

Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com

Investor Relations:

Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BNGO present at the H.C. Wainwright @ Home Event?

BNGO will present on October 15, 2025 from 10:00 a.m. to 11:00 a.m. ET.

Who from Bionano will speak at the October 15, 2025 BNGO presentation?

Erik Holmlin, PhD, Bionano's president and CEO, is the presenter.

How can investors watch BNGO's H.C. Wainwright @ Home webcast on October 15, 2025?

Investors can register via the event webcast link provided by the conference and watch live.

Will there be a replay of the BNGO H.C. Wainwright presentation after October 15, 2025?

Yes. A replay/recording will be posted at ir.bionano.com and available for at least 90 days.

What topics will BNGO cover during the October 15, 2025 presentation?

The announcement lists the presenter and logistics only; it does not specify presentation topics.

Where can I find registration and replay information for BNGO (Nasdaq: BNGO)?

Registration is via the H.C. Wainwright webcast link and replay details will appear on ir.bionano.com.